Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 17, 2021

U.S. Securities and Exchange Commission v. Hall et al

Track this case

Case Number:

3:21-cv-01597

Court:

Ohio Northern

Nature of Suit:

Securities/Commodities

Judge:

James R. Knepp II

Firms

Government Agencies

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 19, 2022

    SEC Gets Consent Win For CEO's COVID-19 Product Claims

    The U.S. Securities and Exchange Commission's case against a biotechnology firm and its chief executive accused of falsely claiming regulators approved of their disinfectants for fighting COVID-19 has resulted in a civil penalty and a prohibition on trading penny stocks, according to a consent judgment approved by an Ohio federal judge.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login